Potential effects of adenosine triphosphate and melatonin on oxidative and inflammatory optic nerve damage in rats caused by 5-fluorouracil
Özet
• AIM: To investigate the effects of adenosine triphosphate (ATP) and melatonin, which have antioxidant and anti-inflammatory activities, on potential 5-fluorouracil (5-FU)-induced optic nerve damage in rats. • METHODS: Twenty-four rats were categorized into four groups of six rats: healthy (HG), 5-FU (FUG), ATP+5-FU (AFU), and melatonin+5-FU (MFU). ATP (4 mg/kg) and melatonin (10 mg/kg) were administered intraperitoneally and orally, respectively. One hour after ATP and melatonin administration, rats in the AFU, MFU, and FUG were intraperitoneally injected with 5-FU (100 mg/kg). ATP and melatonin were administered once daily for 10d. 5-FU was administered at a single dose on days 1, 3, and 5 of the experiment. After 10d, the rats were euthanized and optic nerve tissues were extracted. Optic nerve tissues were biochemically and histopathologically examined. • RESULTS: ATP and melatonin treatments inhibited the increase in malondialdehyde (MDA) and interleukin-6 (IL-6) levels, which were elevated in the FUG. The treatments also prevented the decrease in total glutathione (tGSH) levels and the superoxide dismutase (SOD) and catalase (CAT) activities (P<0.001). This inhibition was higher in the ATP group than in the melatonin group (P<0.001). ATP prevented histopathological damage better than melatonin (P<0.05). • CONCLUSION: ATP and melatonin have the potential to be used in alleviating 5-FU-induced optic nerve damage. In addition, ATP treatment shows better protective effects than melatonin. © 2025 International Journal of Ophthalmology (c/o Editorial Office). All rights reserved.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Somuncu, Ahmet Mehmet | |
| dc.contributor.author | Somuncu, Busra Parlak | |
| dc.contributor.author | Ozbay, Ahmet Duhan | |
| dc.contributor.author | Cicek, Ibrahim | |
| dc.contributor.author | Suleyman, Bahadir | |
| dc.contributor.author | Mammadov, Renad | |
| dc.contributor.author | Bulut, Seval | |
| dc.contributor.author | Tastan, Tugba Bal | |
| dc.contributor.author | Coban, Taha Abdulkadir | |
| dc.contributor.author | Suleyman, Halis | |
| dc.contributor.author | Aydin, Aliyev | |
| dc.date.accessioned | 2026-10-18T20:26:29.450604173Z | |
| dc.date.available | 2026-10-18T20:26:29.450604173Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | • AIM: To investigate the effects of adenosine triphosphate (ATP) and melatonin, which have antioxidant and anti-inflammatory activities, on potential 5-fluorouracil (5-FU)-induced optic nerve damage in rats. • METHODS: Twenty-four rats were categorized into four groups of six rats: healthy (HG), 5-FU (FUG), ATP+5-FU (AFU), and melatonin+5-FU (MFU). ATP (4 mg/kg) and melatonin (10 mg/kg) were administered intraperitoneally and orally, respectively. One hour after ATP and melatonin administration, rats in the AFU, MFU, and FUG were intraperitoneally injected with 5-FU (100 mg/kg). ATP and melatonin were administered once daily for 10d. 5-FU was administered at a single dose on days 1, 3, and 5 of the experiment. After 10d, the rats were euthanized and optic nerve tissues were extracted. Optic nerve tissues were biochemically and histopathologically examined. • RESULTS: ATP and melatonin treatments inhibited the increase in malondialdehyde (MDA) and interleukin-6 (IL-6) levels, which were elevated in the FUG. The treatments also prevented the decrease in total glutathione (tGSH) levels and the superoxide dismutase (SOD) and catalase (CAT) activities (P<0.001). This inhibition was higher in the ATP group than in the melatonin group (P<0.001). ATP prevented histopathological damage better than melatonin (P<0.05). • CONCLUSION: ATP and melatonin have the potential to be used in alleviating 5-FU-induced optic nerve damage. In addition, ATP treatment shows better protective effects than melatonin. © 2025 International Journal of Ophthalmology (c/o Editorial Office). All rights reserved. | |
| dc.identifier.doi | 10.18240/ijo.2025.02.04 | |
| dc.identifier.eissn | 2227-4898 | |
| dc.identifier.endpage | 228 | |
| dc.identifier.issn | 2222-3959 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pmcid | PMC11754014 | |
| dc.identifier.pmid | 39967968 | |
| dc.identifier.scopus | 2-s2.0-85216375459 | |
| dc.identifier.startpage | 222 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/11447 | |
| dc.identifier.volume | 18 | |
| dc.identifier.wos | WOS:001410461800004 | |
| dc.language.iso | en | |
| dc.publisher | International Journal of Ophthalmology (c/o Editorial Office) | |
| dc.relation.ispartof | International Journal of Ophthalmology | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | 5-fluorouracil | |
| dc.subject | adenosine triphosphate | |
| dc.subject | anti-inflammatory | |
| dc.subject | antioxidant | |
| dc.subject | melatonin | |
| dc.subject | optic nerve damage | |
| dc.subject | fluorouracil | |
| dc.subject | glutathione | |
| dc.subject | glutathione peroxidase | |
| dc.subject | glutathione reductase | |
| dc.subject | malonaldehyde | |
| dc.subject | superoxide dismutase | |
| dc.subject | tumor necrosis factor | |
| dc.subject | animal experiment | |
| dc.subject | animal tissue | |
| dc.subject | antiinflammatory activity | |
| dc.subject | antioxidant activity | |
| dc.subject | Article | |
| dc.subject | astrocyte | |
| dc.subject | controlled study | |
| dc.subject | cytokine production | |
| dc.subject | enzyme linked immunosorbent assay | |
| dc.subject | histopathology | |
| dc.subject | inflammation | |
| dc.subject | lipid peroxidation | |
| dc.subject | male | |
| dc.subject | mouse | |
| dc.subject | nonhuman | |
| dc.subject | optic nerve | |
| dc.subject | optic nerve lesion | |
| dc.title | Potential effects of adenosine triphosphate and melatonin on oxidative and inflammatory optic nerve damage in rats caused by 5-fluorouracil | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 4 | |
| rdl.citation.wos | 4 | |
| rdl.department | Department of Ophthalmology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkiey. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkiey. | Department of Histology and Embryology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkiey. | Department of Biochemistry, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
